PNC Financial Services reduced its holdings in Regeneron Pharmaceuticals by 8.8% in the fourth quarter, selling 1,608 shares. Other institutional investors have also adjusted their positions, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback